Prometheus Biosciences In... (RXDX)
NASDAQ: RXDX
· Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM
Prometheus Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -40.88M | -38.76M | -37.27M | -33.65M | -32.07M | -29.92M | -27.33M | -19M | -13.95M | -8.62M | -6.95M |
Depreciation & Amortization | 233K | 212K | 169K | 161K | 87K | 85K | 78K | 56K | 39K | 30K | 30K |
Stock-Based Compensation | 9.38M | 6.92M | 6.03M | 4.64M | 3.28M | 2.45M | 6.25M | 1.2M | 792K | 299K | 176K |
Other Working Capital | -3.12M | 2.85M | 6.48M | 1.8M | -1.23M | 5.2M | 493K | 10.45M | -1.52M | 2.98M | 3.24M |
Other Non-Cash Items | 436K | 437K | -676K | 62K | n/a | 22.27M | 1.28M | 32K | 1.6M | 5.98M | -63K |
Deferred Income Tax | -5M | -1.64M | n/a | n/a | n/a | -22.26M | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.72M | -8.29M | 7.86M | -59K | -688K | 5.2M | 2.75M | 12.35M | -7.48M | -3M | 2.26M |
Operating Cash Flow | -39.54M | -41.12M | -23.9M | -28.85M | -29.39M | -22.18M | -16.98M | -5.36M | -18.99M | -5.32M | -4.54M |
Capital Expenditures | -530K | -369K | -491K | -888K | -955K | -190K | -366K | -282K | -298K | 21K | -39K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -274.4M | -288.18M | -74.52M | -115.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 82.6M | 68.35M | 9.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 626K | -543K |
Investing Cash Flow | -192.33M | -220.2M | -65.76M | -116.86M | -955K | -190K | -366K | -282K | -298K | 647K | -582K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 722K | n/a | n/a | n/a | 428K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 52.8M | 475.33M | 72.11M | 14.63M | 123K | 505K | -7.93M | -1.2M | 276.32M | 45.52M | -1.01M |
Financial Cash Flow | 52.8M | 475.33M | 72.11M | 14.63M | 123K | 505K | -7.93M | -1.2M | 276.32M | 45.52M | -1.01M |
Net Cash Flow | -179.08M | 214.01M | -17.55M | -131.07M | -30.22M | -21.86M | -25.27M | -6.84M | 257.03M | 40.84M | -6.14M |
Free Cash Flow | -40.07M | -41.49M | -24.39M | -29.73M | -30.34M | -22.37M | -17.34M | -5.64M | -19.29M | -5.3M | -4.58M |